[§453-53]  Information sheet.  The department of health shall develop and, upon request, distribute to health professionals subject to this part an information sheet that includes all of the following:

     (1)  A description of expedited partner therapy and its purpose;

     (2)  A notice that an individual who has been treated for a sexually transmitted disease should be retested after treatment to detect possible persistent or recurrent infection, including information on the timing of retesting, as recommended by the Centers for Disease Control and Prevention;

     (3)  A warning about the possible dangers of administering antibiotic therapy to a pregnant individual;

     (4)  Information about antibiotics dispensed or prescribed and dosages of those antibiotics dispensed or prescribed, as recommended by the Centers for Disease Control and Prevention;

     (5)  A warning about the risk of allergies to and drug interactions with the antibiotics described in paragraph (4);

     (6)  Information about sexually transmitted diseases, the treatment of sexually transmitted diseases, and the prevention of sexually transmitted diseases;

     (7)  A notice that the patient and the patient's partners should abstain from sexual activity for seven days after the patient and the partners have completed the antibiotic therapy;

     (8)  A notice that the partners should be tested for sexually transmitted diseases;

     (9)  A notice of the risk to the patient, the partners, and others, including the public health, if a sexually transmitted disease is not completely treated;

    (10)  A notice of the responsibility of the patient to notify sexual partners of the risk of sexually transmitted diseases and the importance of examination and treatment for sexually transmitted diseases; and

    (11)  A statement advising any individual who has any questions regarding anything in the information sheet to contact a health professional or the department of health. [L 2013, c 250, pt of §2]